BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 28857346)

  • 21. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
    Shang Y; Wang LQ; Guo QY; Shi TL
    Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gamabufotalin suppressed osteosarcoma stem cells through the TGF-β/periostin/PI3K/AKT pathway.
    Ma K; Zhang C; Li W
    Chem Biol Interact; 2020 Nov; 331():109275. PubMed ID: 33010222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TSSC3 promotes autophagy via inactivating the Src-mediated PI3K/Akt/mTOR pathway to suppress tumorigenesis and metastasis in osteosarcoma, and predicts a favorable prognosis.
    Zhao GS; Gao ZR; Zhang Q; Tang XF; Lv YF; Zhang ZS; Zhang Y; Tan QL; Peng DB; Jiang DM; Guo QN
    J Exp Clin Cancer Res; 2018 Aug; 37(1):188. PubMed ID: 30092789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. OxLDL-stimulated macrophage exosomes promote proatherogenic vascular smooth muscle cell viability and invasion via delivering miR-186-5p then inactivating SHIP2 mediated PI3K/AKT/mTOR pathway.
    Ren L; Chen S; Yao D; Yan H
    Mol Immunol; 2022 Jun; 146():27-37. PubMed ID: 35421738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BTG2 inhibits the proliferation and metastasis of osteosarcoma cells by suppressing the PI3K/AKT pathway.
    Li YJ; Dong BK; Fan M; Jiang WX
    Int J Clin Exp Pathol; 2015; 8(10):12410-8. PubMed ID: 26722427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
    Zhang Y; Cheng H; Li W; Wu H; Yang Y
    Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-Regulation of Ubiquitin-Specific Peptidase 9X Inhibited Proliferation, Migration and Invasion of Osteosarcoma via ERK1/2 and PI3K/Akt Signaling Pathways.
    Zheng W; Li S; Huang J; Dong Y; Zhang H; Zheng J
    Biol Pharm Bull; 2022; 45(9):1283-1290. PubMed ID: 36047196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-21 promotes proliferation, invasion and suppresses apoptosis in human osteosarcoma line MG63 through PTEN/Akt pathway.
    Lv C; Hao Y; Tu G
    Tumour Biol; 2016 Jul; 37(7):9333-42. PubMed ID: 26779632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p.
    Song L; Zhou Z; Gan Y; Li P; Xu Y; Zhang Z; Luo F; Xu J; Zhou Q; Dai F
    J Cell Biochem; 2019 Jun; 120(6):9656-9666. PubMed ID: 30548308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of FER1L4 promotes the apoptosis and suppresses epithelial-mesenchymal transition and stemness markers via activating PI3K/AKT signaling pathway in osteosarcoma cells.
    Ma L; Zhang L; Guo A; Liu LC; Yu F; Diao N; Xu C; Wang D
    Pathol Res Pract; 2019 Jun; 215(6):152412. PubMed ID: 31000382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upregulated LEPRE1 correlates with poor outcome and its knockdown attenuates cells proliferation, migration and invasion in osteosarcoma.
    Huang Z; Wang Q; Wang Y; Zhao L; Cao Z; Cui C; Yu D; Liu B
    Anticancer Drugs; 2020 Apr; 31(4):326-332. PubMed ID: 32197005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Up-regulation of LINC00619 promotes apoptosis and inhibits proliferation, migration and invasion while promoting apoptosis of osteosarcoma cells through inactivation of the HGF-mediated PI3K-Akt signalling pathway.
    Zi X; Zhang G; Qiu S
    Epigenetics; 2022; 17(2):147-160. PubMed ID: 33797312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inositol polyphosphate-4-phosphatase type II and rucaparib treatment inhibit the growth of osteosarcoma cells dependent on phosphoinositide 3-kinase/protein kinase B pathway.
    Li D; Yang J; Ma H; Sun C; Feng R
    J Cell Biochem; 2018 Dec; 119(12):9899-9909. PubMed ID: 30132953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aplasia Ras homologue member Ⅰ overexpression inhibits tumor growth and induces apoptosis through inhibition of PI3K/Akt survival pathways in human osteosarcoma MG-63 cells in culture.
    Ye K; Wang S; Yang Y; Kang X; Wang J; Han H
    Int J Mol Med; 2015 Sep; 36(3):776-82. PubMed ID: 26165148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long Non-Coding RNA Urothelial Carcinoma Associated 1 Promotes Proliferation, Migration and Invasion of Osteosarcoma Cells by Regulating microRNA-182.
    Li Q; Xing W; Gong X; Wang Y
    Cell Physiol Biochem; 2018; 51(3):1149-1163. PubMed ID: 30481751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PENK inhibits osteosarcoma cell migration by activating the PI3K/Akt signaling pathway.
    Zhang HP; Yu ZL; Wu BB; Sun FR
    J Orthop Surg Res; 2020 Apr; 15(1):162. PubMed ID: 32334633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. K-Ras
    Zhang J; Liu W; Dong H; Wang W
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2048-2057. PubMed ID: 31126199
    [No Abstract]   [Full Text] [Related]  

  • 38. PLEK2 mediates metastasis and vascular invasion via the ubiquitin-dependent degradation of SHIP2 in non-small cell lung cancer.
    Wu DM; Deng SH; Zhou J; Han R; Liu T; Zhang T; Li J; Chen JP; Xu Y
    Int J Cancer; 2020 May; 146(9):2563-2575. PubMed ID: 31498891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoxia-inducible factor-1 promotes cancer progression through activating AKT/Cyclin D1 signaling pathway in osteosarcoma.
    Zhang B; Li YL; Zhao JL; Zhen O; Yu C; Yang BH; Yu XR
    Biomed Pharmacother; 2018 Sep; 105():1-9. PubMed ID: 29807229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenovirus-mediated overexpression of BMP-9 inhibits human osteosarcoma cell growth and migration through downregulation of the PI3K/AKT pathway.
    Li B; Yang Y; Jiang S; Ni B; Chen K; Jiang L
    Int J Oncol; 2012 Nov; 41(5):1809-19. PubMed ID: 22948234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.